Smith & Nephew is a medical technology company. Co. has a global franchise structure with three franchises: Orthopaedics, which includes a range of Hip and Knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies, and services that empower surgeons, and Trauma and Extremities products used to stabilise severe fractures and correct hard tissue deformities; Sports Medicine and Ear, Nose and Throat, which provide products and instruments used to repair or remove soft tissue; and Advance Wound Management, which provides a set of products and services to meet clinical needs. When considering the Smith & Nephew Plc stock dividend history, we have taken known splits into account, such that the SNN dividend history is presented on a split-adjusted ("apples to apples") basis. Smith & Nephew Plc dividend history is presented both in graphical/chart form, and as a SNN dividend history data table along the right-hand column.
|
SNN Stock Dividend HistoryThe SNN dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable SNN historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the SNN dividend history record. Also see the SNN stock dividend history data table along the right-hand column below. |
|
|
Strong Buy (3.50 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: SNN Forecast Based on data provided by Zacks Investment Research via Quandl.com |